Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis

PR Newswire·Sep 10

This story is reported by PR Newswire. Read what other outlets are saying below, then open the original report for full details.